Federal regulators have denied Johnson & Johnson's request to expand approval of its blood thinner Xarelto for a new use to prevent life-threatening blood clots in high-risk patients.
A majority of Food and Drug Administration panelists have voted against a new use for Johnson & Johnson's blood thinner Xarelto to reduce life-threatening blood clots.
It appears that you already have an account created within our VIP network of sites on . To keep your points and personal information safe, we need to verify that it's really you. To activate your account, please confirm your password. When you have confirmed your password, you will be able to log in through Facebook on both sites.
*Please note that your points, prizes and activities will not be shared between programs within our VIP network.
Welcome back to New Jersey 101.5
It appears that you already have an account on this site associated with . To connect your existing account with your Facebook account, just click on the account activation button below. You will maintain your existing profile and VIP program points. After you do this, you will be able to always log in to http://nj1015.com using your Facebook account.
